Skip to main content
BMC Public Health logoLink to BMC Public Health
. 2026 Jun 25;26:2802. doi: 10.1186/s12889-026-28209-z

COVID-19-related disruptions and measles vaccination uptake among children attending urban health centers in Guelmim, Morocco: a cross-sectional study

Abdelghani Asraoui 1,2,✉, Abdelmajid Soulaymani 1
PMCID: PMC13637358  PMID: 42343352

Abstract

Background

The COVID-19 pandemic disrupted routine immunization services and may have widened measles immunity gaps. Morocco has experienced a widespread measles outbreak since late 2023. This study assessed the association between COVID-19-related disruptions and measles vaccination uptake among children in Guelmim, Morocco, and described additional informational and access barriers.

Methods

A descriptive cross-sectional study was conducted from March to May 2025 in three urban public health centers in Guelmim. Using an interviewer-administered questionnaire, data were collected from 350 mothers of children aged 0–59 months.

Descriptive statistics and Pearson’s chi-square tests were used to examine associations between child measles vaccination status and COVID-19-related, informational, and access-related factors.

Results

Only 44.29% of children were reported as vaccinated against measles. Lower uptake was significantly associated with delaying child vaccination during COVID-19 (27.27% vaccinated vs. 69.61% among those reporting no delay; p < 0.001), missing a measles dose during the pandemic (28.64% vs. 67.96%; p < 0.001), insufficient vaccine information (28.19% vs. 73.98%; p < 0.001), lack of trust in vaccines offered by the public health system (28.29% vs. 68.92%; p < 0.001), difficulty accessing vaccination services (35.88% vs. 69.32%; p < 0.001), and lack of information on post-pandemic vaccination dates (25.00% vs. 68.83%; p < 0.001). Receipt of a measles catch-up dose was strongly associated with vaccination uptake (82.79% among those receiving catch-up; p < 0.001).

Conclusions

In this urban sample, measles vaccination uptake was low and was associated with both COVID-19-related service disruptions and broader informational, trust, and access barriers. Strengthening catch-up activities, service communication, and trust-building strategies may help close immunity gaps in similar settings.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12889-026-28209-z.

Keywords: Measles, COVID-19, Routine immunization, Vaccine confidence, Catch-up vaccination, Morocco

Introduction

Measles remains one of the most contagious vaccine-preventable diseases and continues to threaten child health despite the availability of a safe and highly effective vaccine [1, 2].

Sustained population protection requires high two-dose coverage, because even modest declines in vaccination uptake can rapidly create immunity gaps and enable outbreaks [1, 2].

The COVID-19 pandemic interrupted immunization services worldwide through movement restrictions, service reorganization, supply interruptions, and fear of exposure in health facilities [3–5]. These disruptions slowed or reversed progress in routine childhood vaccination in many countries, especially where health systems already faced communication, access, or trust challenges [4, 5].

In Morocco, measles vaccination is provided through the national immunization program in a two-dose schedule, with the first dose at 9 months and the second between 15 and 18 months [6]. Since late 2023, Morocco has experienced a widespread measles outbreak affecting all 12 regions; by 13 April 2025, more than 25,000 suspected cases, 13,706 laboratory-confirmed cases, and 184 deaths had been reported [6]. At the same time, official sources emphasize that the 95% coverage threshold needed to sustain elimination has not been achieved uniformly in recent years [6, 7].

The Moroccan experience during the pandemic also suggests pressure on routine childhood immunization services. An earlier survey of Moroccan pediatricians described a substantial decline in childhood vaccination during the COVID-19 period and called for corrective measures to restore routine vaccination activities [8]. However, local evidence from caregivers remains limited, particularly in southern urban settings such as Guelmim, where service access and public confidence may vary substantially.

This study therefore aimed to assess the association between COVID-19-related disruptions and measles vaccination uptake among children under five attending urban health centers in Guelmim, while also documenting broader informational, attitudinal, and access-related factors that may shape vaccination behavior in the post-pandemic period.

Methods

Study design and setting

A descriptive cross-sectional survey was conducted between March and May 2025 in the city of Guelmim, southern Morocco. Data were collected in three urban public health centers-Amhayrich, Tayert, and Gramez-which provide routine maternal and child health services, including childhood vaccination. These facilities were selected because they are routine urban entry points for immunization services in Guelmim. The study was not designed to yield a statistically representative regional estimate; rather, it provides evidence from a facility-based urban sample.

Study population and sampling

Eligible participants were mothers aged 18 years or older who were the primary caregivers of at least one child aged 0–59 months, had resided in Guelmim for at least 12 months, and attended one of the selected facilities during the study period. Mothers with major cognitive impairment affecting comprehension or recall, and temporary visitors to the area, were excluded. A total of 350 mothers were enrolled using convenience sampling, an approach commonly used in facility-based surveys when the target population is encountered in routine care settings [9].

Questionnaire and study variables

Data were collected using a structured interviewer-administered questionnaire adapted from WHO vaccine coverage guidance and WHO/UNICEF vaccine hesitancy frameworks [10, 11].

A pilot test with 15 mothers was used to improve wording and contextual relevance. The questionnaire covered five domains: (1) sociodemographic characteristics; (2) maternal COVID-19 vaccination history; (3) the child’s measles vaccination status and timing; (4) information sources, trust in vaccines, vaccine concerns, and history of vaccine refusal; and (5) access to services, campaign participation, and awareness of catch-up activities. To better reflect the study objective, variables were grouped in the revised manuscript into COVID-19-related factors and broader non-COVID determinants of uptake.

Ethical considerations

Administrative authorization to access the selected health centers was obtained from the Regional Directorate of Health in Guelmim. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Ethical approval was granted by the Biomedical Research Ethics Committee of Rabat (approval No. 89/21). Written informed consent was obtained from all participants prior to the interviews. No personally identifying information was recorded, and all responses were analyzed anonymously.

Statistical analysis

Data entry and cleaning were conducted in Microsoft Excel 2016 and statistical analyses were performed in IBM SPSS Statistics version 27.0. Descriptive statistics are presented as frequencies and percentages. Associations between the child’s measles vaccination status (vaccinated vs. non-vaccinated) and explanatory variables were assessed using Pearson’s chi-square test. Statistical significance was set at p < 0.05. Because the study is cross-sectional and based on self-reported information, the findings are interpreted as associations rather than causal effects.

Results

Among the 350 surveyed mothers, the largest age group was 30–39 years (54.86%), followed by 20–29 years (30.29%). Nearly half had primary education (48.85%), 54.29% were housewives, and 50.86% reported having two children (Table 1).

Table 1.

Sociodemographic characteristics of mothers (N = 350)

Variable Category n %
Mother’s age (years) Under 20 21 6.00
20–29 106 30.29
30–39 192 54.86
40–49 27 7.71
50 or older 4 1.14
Education level No schooling 36 10.29
Primary 171 48.85
College 70 20.00
Secondary 37 10.57
Higher education 36 10.29
Occupation Housewife 190 54.29
Civil servant 34 9.71
Private sector 38 10.86
Self-employed 58 16.57
Unemployed 24 6.86
Other 6 1.71
Number of children 1 62 17.71
2 178 50.86
3 80 22.86
4 or more 30 8.57

Percentages are calculated using N = 350 and displayed to two decimal places

Vaccination-related behaviors and perceptions suggested an environment marked by information and trust constraints. Although 69.14% of mothers had received at least one dose of a COVID-19 vaccine, 59.71% reported postponing or missing a child vaccination during the pandemic, only 35.14% considered themselves sufficiently informed about vaccines, and social media was the most frequently cited source of information (42.86%). Trust in vaccines offered by the public health system was low, with 58.57% reporting no trust. Only 44.29% of children were reported as vaccinated against measles, while 60.86% had missed at least one measles dose during the pandemic (Table 2).

Table 2.

Vaccination-related behaviors, information sources, and measles/COVID-19 perceptions (N = 350)

Variable Category n %
Maternal COVID-19 vaccination Vaccinated 242 69.14
Not vaccinated 108 30.86
Child vaccination delayed during COVID-19 Yes 209 59.71
No 102 29.14
Cannot remember 39 11.15
Self-reported change in attention to vaccination after COVID-19 More attentive 241 68.86
Less attentive 71 20.29
No change 38 10.85
Sufficient vaccine information Yes 123 35.14
No 227 64.86
Main source of vaccine information Social media 150 42.86
Health professionals 72 20.57
Family or friends 70 20.00
Television/radio 44 12.57
Internet (other than social media) 14 4.00
Trust in vaccines offered by public health system Yes 74 21.14
Partial 71 20.29
No 205 58.57
History of vaccine refusal Yes 259 74.00
No 91 26.00
Main vaccine concern Lack of information 173 49.43
Distrust in pharmaceutical companies 60 17.14
Perceived ineffectiveness 51 14.57
Fear of side effects 47 13.43
No concern 19 5.43
Child measles vaccination status Vaccinated 155 44.29
Non-vaccinated 195 55.71
Age at measles vaccination Under 1 year 67 19.14
1–2 years 80 22.86
Older than 2 years 8 2.29
Not applicable (non-vaccinated) 195 55.71
Missed measles vaccine during pandemic Yes 213 60.86
No 103 29.43
Do not remember 34 9.71
Perceived measles as serious Yes 253 72.29
No 85 24.28
Do not know 12 3.43
Observed measles resurgence locally Yes 268 76.57
No 66 18.86
Do not know 16 4.57
Belief that COVID-19 delays contributed to resurgence Yes 253 72.29
No 62 17.71
Do not know 35 10.00
Participation in vaccination campaigns Yes 245 70.00
No 105 30.00
Informed of post-pandemic measles vaccination dates Yes 154 44.00
No 196 56.00
Received measles catch-up dose Yes 122 34.86
No 228 65.14
Difficulty accessing vaccination center Yes 262 74.86
No 88 25.14
Need more information about vaccination Yes 295 84.29
No 55 15.71

Percentages are calculated using N = 350 and displayed to two decimal places

To avoid conflating pandemic-specific and broader determinants, the bivariate results are presented in two separate tables. Table 3 summarizes COVID-19-related factors, whereas Table 4 presents informational, attitudinal, and access-related factors.

Table 3.

COVID-19-related factors associated with child measles vaccination status (N = 350)

Factor Category Non-vaccinated n (%) Vaccinated n (%) p-value
Mother vaccinated against COVID-19 No 52 (48.15) 56 (51.85) 0.057
Yes 143 (59.09) 99 (40.91)
Child vaccination delayed during COVID-19 Do not remember 12 (30.77) 27 (69.23) < 0.001
No 31 (30.39) 71 (69.61)
Yes 152 (72.73) 57 (27.27)
Change in attention to vaccination after COVID-19 No change 14 (36.84) 24 (63.16) < 0.001
Less attentive 25 (35.21) 46 (64.79)
More attentive 156 (64.73) 85 (35.27)
Missed measles dose during pandemic Do not know 10 (29.41) 24 (70.59) < 0.001
No 33 (32.04) 70 (67.96)
Yes 152 (71.36) 61 (28.64)
Belief that COVID-19 delays caused measles return Do not know 10 (28.57) 25 (71.43) < 0.001
No 28 (45.16) 34 (54.84)
Yes 157 (62.06) 96 (37.94)
Participation in vaccination campaigns No 43 (40.95) 62 (59.05) < 0.001
Yes 152 (62.04) 93 (37.96)
Informed of post-pandemic vaccination dates No 147 (75.00) 49 (25.00) < 0.001
Yes 48 (31.17) 106 (68.83)
Received measles catch-up dose No 174 (76.32) 54 (23.68) < 0.001
Yes 21 (17.21) 101 (82.79)

Percentages are calculated within each category of the explanatory variable and displayed to two decimal places

p-values were obtained using Pearson's chi-square test

Table 4.

Informational, attitudinal, and access-related factors associated with child measles vaccination status (N = 350)

Factor Category Non-vaccinated n (%) Vaccinated n (%) p-value
Sufficient vaccine information No 163 (71.81) 64 (28.19) < 0.001
Yes 32 (26.02) 91 (73.98)
Trust in vaccines offered by public health system No 147 (71.71) 58 (28.29) < 0.001
Yes 23 (31.08) 51 (68.92)
Partial 25 (35.21) 46 (64.79)
Ever refused a vaccine No 37 (40.66) 54 (59.34) 0.001
Yes 158 (61.00) 101 (39.00)
Main concern about vaccines None 3 (15.79) 16 (84.21) < 0.001
Side effects 16 (34.04) 31 (65.96)
Effectiveness 19 (37.25) 32 (62.75)
Lack of information 136 (78.61) 37 (21.39)
Distrust in pharmaceutical companies 21 (35.00) 39 (65.00)
Perceived measles as serious Do not know 3 (25.00) 9 (75.00) 0.052
No 44 (51.76) 41 (48.24)
Yes 148 (58.50) 105 (41.50)
Observed local measles resurgence Do not know 4 (25.00) 12 (75.00) 0.017
No 33 (50.00) 33 (50.00)
Yes 158 (58.96) 110 (41.04)
Difficulty accessing vaccination center No 27 (30.68) 61 (69.32) < 0.001
Yes 168 (64.12) 94 (35.88)
Want more vaccine information No 23 (41.82) 32 (58.18) 0.024
Yes 172 (58.31) 123 (41.69)

Percentages are calculated within each category of the explanatory variable and displayed to two decimal places

 p-values were obtained using Pearson's chi-square test

COVID-19-related determinants of measles vaccination uptake

COVID-19-related variables were strongly associated with measles vaccination uptake (Table 3). Children of mothers who reported delaying child vaccination during COVID-19 were much less likely to be vaccinated against measles than those of mothers reporting no delay (27.27% vs. 69.61%; p < 0.001). A similar pattern was observed for missing a measles dose during the pandemic (28.64% vs. 67.96%; p < 0.001). Coverage was also substantially higher among mothers informed of post-pandemic vaccination dates (68.83% vs. 25.00%; p < 0.001) and among those whose child had received a catch-up dose (82.79% vs. 23.68%; p < 0.001).

Participation in vaccination campaigns and the belief that COVID-19-related delays contributed to measles resurgence were also significantly associated with vaccination status. Maternal receipt of a COVID-19 vaccine itself was not significantly associated with child measles vaccination (p = 0.057).

Informational, attitudinal, and access-related determinants

Broader informational, attitudinal, and access-related factors were likewise associated with measles vaccination status (Table 4). Coverage was much higher among mothers reporting sufficient vaccine information (73.98% vs. 28.19%; p < 0.001) and among those who trusted vaccines offered by the public health system (68.92% vs. 28.29%; p < 0.001). A previous history of vaccine refusal was negatively associated with measles vaccination uptake (59.34% vaccinated among those reporting no prior refusal vs. 39.00% among those reporting refusal; p = 0.001). Lack of information was the most frequently cited vaccine concern and corresponded to the lowest vaccination uptake (21.39%; p < 0.001). Difficulty accessing vaccination centers was also strongly associated with non-vaccination (35.88% vaccinated among those reporting difficulty vs. 69.32% among those reporting no difficulty; p < 0.001).

Perceiving measles as a serious disease showed a borderline association with uptake (p = 0.052).

Discussion

This revised analysis shows that measles vaccination uptake in this urban sample from Guelmim was low (44.29%) and that lower uptake was associated with both pandemic-related service disruptions and broader structural and informational barriers. The finding is concerning in the Moroccan context because measles transmission intensified nationally after late 2023 despite a long-standing two-dose measles schedule within the national immunization program [6, 7].

The COVID-19 period appears to have been an important context for missed opportunities for vaccination. Mothers who reported delaying child vaccination during COVID-19 or missing a measles dose during the pandemic were substantially less likely to report that their child had been vaccinated. This pattern is consistent with evidence from Morocco and other settings indicating that routine immunization activities were disrupted during the pandemic and required targeted recovery measures [4, 5, 8]. Because the present study is cross-sectional and based on self-report, these findings should be interpreted as perceived and observed associations rather than direct proof of a causal mechanism.

At the same time, the data suggest that the pandemic interacted with barriers that are not unique to COVID-19. The strongest non-pandemic correlates of measles vaccination in this sample were sufficient information, trust in vaccines offered by the public health system, and access to vaccination services. These findings are consistent with broader literature showing that vaccine confidence, service accessibility, and the quality of communication are central determinants of uptake [12–15]. The predominance of social media as a reported information source in this sample does not by itself demonstrate misinformation exposure, but it does indicate that immunization communication competes with informal and potentially unreliable channels and therefore requires proactive public health engagement [14, 15].

The revised presentation also helps distinguish COVID-19-related determinants from more general vaccination determinants. This distinction is important because not all low uptake observed in 2025 can be attributed solely to the pandemic. Broader issues-such as low confidence in public vaccines, prior refusal, and access difficulties-likely predated the pandemic but may have constrained recovery afterwards. In that respect, the Guelmim findings align with literature showing that measles resurgence often reflects a combination of recent service interruption and pre-existing vulnerability in coverage, confidence, or access [6, 13, 16].

Catch-up activities emerged as one of the clearest programmatic signals in this study.

Children who received a measles catch-up dose and mothers who were informed of post-pandemic vaccination dates had substantially higher coverage than their counterparts. This supports the importance of catch-up and supplementary immunization activities in closing immunity gaps after service disruption [17]. In practice, these results suggest that recovery strategies should not rely only on the availability of doses, but also on timely communication, community outreach, and visible efforts to rebuild confidence in routine services.

Several limitations should be considered. First, the cross-sectional design precludes causal inference. Second, all data were self-reported and vaccination status was not verified against immunization cards or health records. Third, the convenience sample was drawn from urban public health centers and cannot be generalized to all mothers in Guelmim or to rural populations. Finally, the questionnaire included both pandemic-specific variables and broader vaccination perception variables; this was useful for understanding the post-pandemic context, but it also means that the study addresses measles vaccination uptake more broadly than COVID-19 effects alone.

Conclusion

In this facility-based urban sample from Guelmim, measles vaccination uptake among children under five was suboptimal and was associated with both COVID-19-related disruption indicators and broader barriers related to information, trust, and service access.

The findings support strengthening catch-up vaccination, improving communication on vaccination schedules, and investing in confidence-building strategies rooted in routine primary care and community outreach. Future work using verified immunization records and broader sampling frames would help clarify the relative contribution of pandemic-related and long-standing determinants.

Supplementary Information

Supplementary Material 1. (37.3KB, docx)

Acknowledgements

During manuscript revision, the authors used a generative AI tool to support language refinement and structural editing. All scientific content, interpretation, references, and final wording were reviewed and approved by the authors, who take full responsibility for the manuscript.

Authors' contributions

A.A. was responsible for the research concept, literature review, development of the study method, data collection, analysis, and preparation of the manuscript. A.S. was responsible for supervision, reviewing and editing.

Funding

The authors received no specific funding for this study.

Data availability

Data supporting the findings of this study are available, upon request from the main author A.A.

Declarations

Ethics approval and consent to participate

Administrative authorization to conduct the survey in the selected health centers was obtained from the Regional Directorate of Health in Guelmim. The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was granted by the Biomedical Research Ethics Committee of Rabat (approval No. 89/21). Written informed consent was obtained from all participants prior to the interviews.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Minta AA, Ferrari M, Chard AN, et al. Progress toward measles elimination - Worldwide, 2000–2023. MMWR Morb Mortal Wkly Rep. 2024;73(45):1036–42. 10.15585/mmwr.mm7345a4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Moss WJ, Measles. Lancet. 2017;390(10111):2490–502. 10.1016/S0140-6736(17)31463-0. [DOI] [PubMed] [Google Scholar]
  • 3.UNICEF Innocenti - Global office of research and foresight. The State of the World’s Children 2023: For Every Child, Vaccination. Florence: UNICEF; 2023. [Google Scholar]
  • 4.Hartner AM, Li X, Gaythorpe K. COVID-19 related disruption and resilience in immunisation activities in LMICs: a rapid review. BMJ Open. 2024;14(8):e076607. 10.1136/bmjopen-2023-076607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Shet A, Carr K, Danovaro-Holliday MC, et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health. 2022;10(2):e186–94. 10.1016/S2214-109X(21)00512-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.World Health Organization. Disease outbreak news: measles in Morocco. World Health Organization; 2025. Revised May 16. https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON568.
  • 7.World Health Organization; UNICEF, Morocco. WHO and UNICEF estimates of immunization coverage: 2023 revision. 2 July 2024.
  • 8.Chekhlabi N, Dini N, Arrab R, Ettair S. Effects of the COVID-19 pandemic on childhood immunization in Morocco: electronic survey of 103 pediatricians. Pan Afr Med J. 2021;38:134. 10.11604/pamj.2021.38.134.24104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Etikan I. Comparison of convenience sampling and purposive sampling. Am J Theor Appl Stat. 2016;5(1):1–4. 10.11648/j.ajtas.20160501.11. [DOI] [Google Scholar]
  • 10.Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF Joint Reporting Form data, 2015–2017. Vaccine. 2018;36(26):3861–7. 10.1016/j.vaccine.2018.03.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.World Health Organization. Immunization in practice: a practical guide for health staff. 2015 update. Geneva: World Health Organization; 2015. [Google Scholar]
  • 12.De Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020;396(10255):898–908. 10.1016/S0140-6736(20)31558-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9. 10.1016/j.vaccine.2014.01.081. [DOI] [PubMed] [Google Scholar]
  • 14.Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Health. 2020;5(10):e004206. 10.1136/bmjgh-2020-004206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586–93. 10.1080/21645515.2020.1780846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Robert A, Kucharski AJ, Funk S. The impact of local vaccine coverage and recent incidence on measles transmission in France between 2009 and 2018. BMC Med. 2022;20(1):77. 10.1186/s12916-022-02277-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.World Health Organization. Planning and implementing high-quality supplementary immunization activities for injectable vaccines using an example of measles and rubella vaccines: field guide. Geneva: World Health Organization; 2016. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1. (37.3KB, docx)

Data Availability Statement

Data supporting the findings of this study are available, upon request from the main author A.A.


Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES